207 related articles for article (PubMed ID: 35718282)
41. COVID-19 vaccination in cancer patients: a narrative review.
Seneviratne SL; Yasawardene P; Wijerathne W; Somawardana B
J Int Med Res; 2022 Mar; 50(3):3000605221086155. PubMed ID: 35313761
[TBL] [Abstract][Full Text] [Related]
42. Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.
Sheng WH; Chang SY; Lin PH; Hsieh MJ; Chang HH; Cheng CY; Yang HC; Pan CF; Ieong SM; Chao TL; Chen JP; Cheng SH; Chang SC
J Formos Med Assoc; 2022 Apr; 121(4):766-777. PubMed ID: 35305895
[TBL] [Abstract][Full Text] [Related]
43. Easy approach to detect cell immunity to COVID vaccines in common variable immunodeficiency patients.
Barrios Y; Franco A; Alava-Cruz C; Cuesta-Martin R; Camara C; Matheu V
Allergol Immunopathol (Madr); 2022; 50(3):101-105. PubMed ID: 35527662
[TBL] [Abstract][Full Text] [Related]
44. T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine.
Atanackovic D; Kreitman RJ; Cohen J; Hardy NM; Omili D; Iraguha T; Burbelo PD; Gebru E; Fan X; Baddley J; Luetkens T; Dahiya S; Rapoport AP
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35851312
[TBL] [Abstract][Full Text] [Related]
45. Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial.
Bonelli M; Mrak D; Tobudic S; Sieghart D; Koblischke M; Mandl P; Kornek B; Simader E; Radner H; Perkmann T; Haslacher H; Mayer M; Hofer P; Redlich K; Husar-Memmer E; Fritsch-Stork R; Thalhammer R; Stiasny K; Winkler S; Smolen JS; Aberle JH; Zeitlinger M; Heinz LX; Aletaha D
Ann Rheum Dis; 2022 May; 81(5):687-694. PubMed ID: 35027397
[TBL] [Abstract][Full Text] [Related]
46. Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.
Tortorella C; Aiello A; Gasperini C; Agrati C; Castilletti C; Ruggieri S; Meschi S; Matusali G; Colavita F; Farroni C; Cuzzi G; Cimini E; Tartaglia E; Vanini V; Prosperini L; Haggiag S; Galgani S; Quartuccio ME; Salmi A; Repele F; Altera AMG; Cristofanelli F; D'Abramo A; Bevilacqua N; Corpolongo A; Puro V; Vaia F; Capobianchi MR; Ippolito G; Nicastri E; Goletti D;
Neurology; 2022 Feb; 98(5):e541-e554. PubMed ID: 34810244
[TBL] [Abstract][Full Text] [Related]
47. Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy.
Sidler D; Born A; Schietzel S; Horn MP; Aeberli D; Amsler J; Möller B; Njue LM; Medri C; Angelillo-Scherrer A; Borradori L; Seyed Jafari SM; Radonjic-Hoesli S; Chan A; Hoepner R; Bacher U; Mani LY; Iype JM; Suter-Riniker F; Staehelin C; Nagler M; Hirzel C; Maurer B; Moor MB
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35361691
[TBL] [Abstract][Full Text] [Related]
48. Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity.
Einarsdottir S; Martner A; Waldenström J; Nicklasson M; Ringlander J; Arabpour M; Törnell A; Wiktorin HG; Nilsson S; Bittar R; Nilsson M; Lisak M; Veje M; Friman V; Al-Dury S; Bergström T; Ljungman P; Brune M; Hellstrand K; Lagging M
Blood Adv; 2022 May; 6(9):2723-2730. PubMed ID: 35286374
[TBL] [Abstract][Full Text] [Related]
49. Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy.
Jedicke N; Stankov MV; Cossmann A; Dopfer-Jablonka A; Knuth C; Ahrenstorf G; Ramos GM; Behrens GMN
HIV Med; 2022 May; 23(5):558-563. PubMed ID: 34725907
[TBL] [Abstract][Full Text] [Related]
50. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.
O'Connor MA; Erasmus JH; Randall S; Archer J; Lewis TB; Brown B; Fredericks M; Groenier S; Iwayama N; Ahrens C; Garrison W; Wangari S; Guerriero KA; Fuller DH
Front Immunol; 2021; 12():800723. PubMed ID: 34992610
[TBL] [Abstract][Full Text] [Related]
51. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
Scaggs Huang F
J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
[TBL] [Abstract][Full Text] [Related]
52. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA
BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521
[TBL] [Abstract][Full Text] [Related]
53. Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients.
Harberts A; Schaub GM; Ruether DF; Duengelhoef PM; Brehm TT; Karsten H; Fathi A; Jahnke-Triankowski J; Fischer L; Addo MM; Haag F; Luetgehetmann M; Lohse AW; Schulze Zur Wiesch J; Sterneck M
Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2558-2566.e5. PubMed ID: 35850415
[TBL] [Abstract][Full Text] [Related]
54. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women.
Blakeway H; Amin-Chowdhury Z; Prasad S; Kalafat E; Ismail M; Abdallah FN; Rezvani A; Amirthalingam G; Brown K; Le Doare K; Heath PT; Ladhani SN; Khalil A
Ultrasound Obstet Gynecol; 2022 Nov; 60(5):673-680. PubMed ID: 36318630
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report.
McDonnell J; Cousins K; Younger MEM; Lane A; Abolhassani H; Abraham RS; Al-Tamemi S; Aldave-Becerra JC; Al-Faris EH; Alfaro-Murillo A; AlKhater SA; Alsaati N; Doss AMA; Anderson M; Angarola E; Ariue B; Arnold DE; Assa'ad AH; Aytekin C; Bank M; Bergerson JRE; Bleesing J; Boesing J; Bouso C; Brodszki N; Cabanillas D; Cady C; Callahan MA; Caorsi R; Carbone J; Carrabba M; Castagnoli R; Catanzaro JR; Chan S; Chandra S; Chapdelaine H; Chavoshzadeh Z; Chong HJ; Connors L; Consonni F; Correa-Jimenez O; Cunningham-Rundles C; D'Astous-Gauthier K; Delmonte OM; Demirdag YY; Deshpande DR; Diaz-Cabrera NM; Dimitriades VR; El-Owaidy R; ElGhazali G; Al-Hammadi S; Fabio G; Faure AS; Feng J; Fernandez JM; Fill L; Franco GR; Frenck RW; Fuleihan RL; Giardino G; Galant-Swafford J; Gambineri E; Garabedian EK; Geerlinks AV; Goudouris E; Grecco O; Pan-Hammarström Q; Khani HHK; Hammarström L; Hartog NL; Heimall J; Hernandez-Molina G; Horner CC; Hostoffer RW; Hristova N; Hsiao KC; Ivankovich-Escoto G; Jaber F; Jalil M; Jamee M; Jean T; Jeong S; Jhaveri D; Jordan MB; Joshi AY; Kalkat A; Kanarek HJ; Kellner ES; Khojah A; Khoury R; Kokron CM; Kumar A; Lecerf K; Lehman HK; Leiding JW; Lesmana H; Lim XR; Lopes JP; López AL; Tarquini L; Lundgren IS; Magnusson J; Marinho AKBB; Marseglia GL; Martone GM; Mechtler AG; Mendonca L; Milner JD; Mustillo PJ; Naderi AG; Naviglio S; Nell J; Niebur HB; Notarangelo L; Oleastro M; Ortega-López MC; Patel NR; Petrovic G; Pignata C; Porras O; Prince BT; Puck JM; Qamar N; Rabusin M; Raje N; Regairaz L; Risma KA; Ristagno EH; Routes J; Roxo-Junior P; Salemi N; Scalchunes C; Schuval SJ; Seneviratne SL; Shankar A; Sherkat R; Shin JJ; Siddiqi A; Signa S; Sobh A; Lima FMS; Stenehjem KK; Tam JS; Tang M; Barros MT; Verbsky J; Vergadi E; Voelker DH; Volpi S; Wall LA; Wang C; Williams KW; Wu EY; Wu SS; Zhou JJ; Cook A; Sullivan KE; Marsh R
J Clin Immunol; 2024 Apr; 44(4):86. PubMed ID: 38578389
[TBL] [Abstract][Full Text] [Related]
57. COVID-19 and Inborn Errors of Immunity.
Delmonte OM; Castagnoli R; Notarangelo LD
Physiology (Bethesda); 2022 Nov; 37(6):0. PubMed ID: 35944006
[TBL] [Abstract][Full Text] [Related]
58. Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort study.
Katzenstein TL; Rasmussen LD; Drabe CH; Larsen CS; Hansen AE; Stærkind M; Knudsen LS; Hansen CH; Obel N
Front Immunol; 2022; 13():994253. PubMed ID: 36211430
[TBL] [Abstract][Full Text] [Related]
59. The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet).
Giardino G; Milito C; Lougaris V; Punziano A; Carrabba M; Cinetto F; Scarpa R; Dellepiane RM; Ricci S; Rivalta B; Conti F; Marzollo A; Firinu D; Cirillo E; Lagnese G; Cancrini C; Martire B; Danieli MG; Pession A; Vacca A; Azzari C; Fabio G; Soresina A; Agostini C; Spadaro G; Badolato R; Cicalese MP; Aiuti A; Plebani A; Quinti I; Pignata C
J Clin Immunol; 2022 Jul; 42(5):935-946. PubMed ID: 35445287
[TBL] [Abstract][Full Text] [Related]
60. Letter to the Editor Regarding "Antibody Production after COVID-19 Vaccination in Patients with Inborn Errors of Immunity".
Deshpande N
Iran J Immunol; 2024 Mar; 21(1):101-102. PubMed ID: 38469794
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
